the second ORAL drug for relapsing-remitting multiple sclerosis (MS), Tecfidera (TEK-fi-de-rah, dimethyl fumarate)
May 2013
You'll hear about the second ORAL drug for relapsing-remitting multiple sclerosis (MS), Tecfidera (TEK-fi-de-rah, dimethyl fumarate).
Think of it as a form of fumaric acid. It's a new therapy for MS...but has been used for years in Europe for psoriasis.
Tecfidera seems to protect neurons and myelin and have anti-inflammatory effects.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive